Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Worldwide Sales and Major Product Performance
MRK logo

Merck Sales Hit $16.3 Billion as $9 Billion Acquisition Charge Triggers Quarterly Loss

MRK8-KFiling Date: 4/30/2026
Merck & Co., Inc.
Description

What this story covers

Merck reported a 5% sales increase to $16.3 billion, driven by oncology and new launches. However, a $9.0 billion acquisition charge for Cidara Therapeutics led to a GAAP net loss, even as the company raised full-year sales guidance.

Story snapshot

CompanyMerck & Co., Inc.
TickerMRK
VariantStandard detailed
Duration5:51
Filing type8-K
PeriodQ2 2026
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-052081
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in